 NeoGenomics, Inc. NASDAQ:NEO Q2 2022 Earnings Conference Call August 9, 2022 8:30 AM ET Company Participants Lynn Tetrault Interim CEO Charlie Eidson Director of Investor Relations Bill Bonello Chief Financial Officer Chris Smith Incoming Chief Executive Officer David Sholehvar President, Clinical Division Vishal Sikri President, Pharma Services Division and President-Inivata Conference Call Participants Brian Weinstein William Blair Alex Nowak Craig-Hallum David Westenberg Piper Sandler Puneet Souda SVB Securities Dan Brennan Cowen Andrew Cooper Raymond James Mark Massaro BTIG Derik de Bruin Bank of America Yuko Oku Morgan Stanley David Delahunt Goldman Sachs Mike Matson Needham Mason Carrico Stephens, Inc. Operator Good day, ladies and gentlemen, and welcome to the NeoGenomics Second Quarter 2022 Earnings Call. At this time, all participants have been placed on a listen-only mode and the floor will be open for questions and comments after the presentation. 